Thrombocytopenia in association with splenomegaly during granulocyte-colony-stimulating factor treatment in mice is not caused by hypersplenism and is resolved spontaneously

Transfusion

Volumn 47, Issue 1, 2007, Pages 41-49

  Takamatsu, Yasushi ^a   Jimi, Shiro ^a   Sato, Tomohito ^a   Hara, Shuuji ^a   Suzumiya, Junji ^a   Tamura, Kazuo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE ESCALATION; HISTOLOGY; HYPERSPLENISM; MALE; MOUSE; NONHUMAN; SPLEEN WEIGHT; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTE LIFESPAN; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HYPERSPLENISM; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; PLATELET COUNT; REMISSION, SPONTANEOUS; SPLEEN; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTOPENIA;

EID: 33845747778     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01061.x     Document Type: Article

References (20)

1. Anderlini P, Korbling M, Dale D, et al. Allogeneic blood stem cell transplantation: consideration for donors. Blood 1997;90:903-8.
2. Murata M, Harada M, Kato S, et al. Peripheral blood stem cell mobilization and apheresis: analysis of adverse event in 94 normal donors. Bone Marrow Transplant 1999;24:1065-71.
3. Platzbecker U, Prange-Krex G, Bornhauser M, et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 2001;41:184-9.
4. Falzetti F, Aversa F, Minelli O, et al. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet 1999;353:555.
5. Martinez C, Urbano-Ispizua A, Mazzara R, et al. Granulocyte colony-stimulating factor administration and peripheral blood progenitor cells collection in normal donors: analysis of leukapheresis-related side effects. Blood 1996;87:4916-7.
6. Holtzer CD, Stanley HD, Jacobson MA. Severe reversible thrombocytopenia caused by recombinant human granulocyte colony-stimulating factor in an AIDS patient receiving chronic ganciclovir therapy. AIDS 1997;11:1403-5.
7. Przepiorka D, Smith T, Folloder J, et al. Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors. Blood 2001;97:3405-10.
8. McNiece IK, McGrath HE, Quesenberry PJ. Granulocyte colony-stimulating factor augments in vitro megakaryocyte colony formation by interleukin-3. Exp Hematol 1988;16:807-10.
9. Metcalf D, di Rago L, Mifsud S. Synergistic and inhibitory interactions in the in vitro control of murine megakaryocyte colony formation. Stem Cells 2002;20:552-60.
10. Fujita T, Yamada T, Hashiguchi A, et al. Augmentation of megakaryocytopoiesis within the hematopoietic microenvironment of human granulocyte colony-stimulating factor transgenic mice. Exp Hematol 2001;29:1010-8.
11. Takamatsu Y, Simmons PJ, Moore RJ, et al. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood 1998;92:3465-73.
12. Kaplan JE, Saba TM. Platelet removal from the circulation by the liver and spleen. Am J Physiol 1978;235:H314-20.
13. Aster RH. Pooling of platelets in the spleen. Role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 1966;45:645-57.
14. Malachowski ME, Comenzo RL, Hillyer CD, et al. Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 1992;32:732-5.
15. Yang FC, Tsuji K, Oda A, et al. Differential effects of human granulocyte colony-stimulating factor (hG-CSF) and thrombopoietin on megakaryopoiesis and platelet function in hG-CSF receptor-transgenic mice. Blood 1999;94:950-8.
16. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediated interaction of hemopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nature Med 2004;10:64-71.
17. Levesque JP, Takamatsu Y, Nilsson SK, et al. Vascular cell adhesion molecule-1 is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001;98:1289-97.
18. Levesque JP, Hendy J, Takamatsu Y, et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;110:187-96.
19. Molineux G, Pojda Z, Dexter TM. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 1990;75:563-9.
20. Nakayama T, Kudo H, Suzuki S, et al. Splenomegaly induced by recombinant human granulocyte-colony stimulating factor in rats. Life Sci 2001;69:1521-9.